Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/Core EBITDA

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 14.3411.4511.2112.7717.14

What is the latest EV/Core EBITDA ratio of INDOCO REMEDIES ?

The latest EV/Core EBITDA ratio of INDOCO REMEDIES is 14.34 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202414.34
Mar202311.45
Mar202211.21
Mar202112.77
Mar202017.14

How is EV/Core EBITDA of INDOCO REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 14.34
25.24
Mar2023 11.45
2.14
Mar2022 11.21
-12.22
Mar2021 12.77
-25.50
Mar2020 17.14 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/Core EBITDA ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,760.0 Cr -7.6% -9.1% -7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,607.0 Cr -5.9% -2.8% -5.3% Stock Analytics
DIVIS LABORATORIES ₹170,148.0 Cr -3.7% -6.9% 30.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,471.0 Cr -3.8% 7.1% 12% Stock Analytics
CIPLA ₹121,103.0 Cr -3.9% -0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,306.0 Cr -6% -7.3% -12% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-7.6%

-9.1%

-7%

SENSEX

-0.8%

-3.3%

-1.4%


You may also like the below Video Courses